Best Choice between aripiprazole and risperidone in methamphetamine psychosis

Phase 3

Recruiting

• Conditions: Metamphetamin induced psychotic disorder.; Other stimulant abuse with stimulant-induced psychotic disorder; F15.15

• Registration Number: IRCT20220103053615N1
• Lead Sponsor: niversity of social welfare and rehabilitation sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Men and women with written informed consent to enter the trial
At least one Positive and Negative Syndrome Scale score equal or greater than 4
Methamphetamine use in less than 4 weeks leading to admition
No other substance dependencies except for Tobacco
diagnosis of Metamphetamin induced psychotic disorder according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition

Exclusion Criteria

Sever nonpsychiatric condition in which Risperidone or Aripiprazole are contraindicated
Aripiprazole or Risperidone Allergies
Active suicidal or homicidal thoughts
Comorbid mood or anxiety disorders
Pregnant or nursing women or high suspicion of pregnancy
Psychiatric medication use in last 4 weeks other than Benzodiazepines

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of Positive and Negative Syndrome Scale. Timepoint: Days: 0, 7, 28 after medication. Method of measurement: Positive and Negative Syndrome Scale.